loading
Oviya MedSafe - Regulatory Pursuit Beyond Pharmacovigilance

Dear Well-wishers,

I am heartened much more than usual to reach out to you through this April 2019 edition of Oviya MedSafe’s newsletter, thanks to many of your kind words of compliments on the occasion of the 7th Anniversary of Oviya MedSafe’s founding that was featured in our March 2019 newsletter.

Entering into our eighth year of existence is indeed an exciting moment for all of us at Oviya MedSafe. While we were busy the whole of March rightfully appreciating ourselves for our genuine achievements, I have started thinking since the beginning of April about the road ahead for Oviya MedSafe. Given the ever-changing global pharmacovigilance scenario, Oviya MedSafe has, without any doubt, been quite successful in conceptualizing, packaging and delivering customized consultancy and outsourced services in pharmacovigilance to all kinds of clientele. With this stronghold in place, I believe the time has come for Oviya MedSafe to spread our wings beyond pharmacovigilance, for propelling us into the next phase of growth.

As the first step, Oviya MedSafe is considering setting up a Regulatory Consulting Services portfolio in a phased manner. Regulatory Affairs is often seen as the closest cousin of Pharmacovigilance in the industry and truly so. I would further say that these cousins depend on each other as much as they are answerable to each other. Incidentally, regulatory consulting came out as the first option when I brainstormed with my team members on what Oviya MedSafe’s first venture beyond pharmacovigilance should be. Accordingly, we have started the groundwork in this direction. The regulatory services vertical shall either be developed organically or by acquiring a regulatory consulting firm, based on whichever would work for us. Meanwhile, I solicit your kind consideration of Oviya MedSafe for your regulatory service needs in addition to your pharmacovigilance requirements. I am confident that Oviya MedSafe’s regulatory offerings will be well-received and encourage us to add many more of such allied areas of business.

Speaking of regulatory, I am reminded of the agenda of the Indian Pharmacovigilance Day 2019 conference that is to be held under my chairmanship at Hotel Kohinoor Continental, Andheri East, Mumbai on Friday 26th July 2019, as it has coincidentally come out as an assortment of topics that deal with the relationship between Regulatory Affairs and Pharmacovigilance. Apart from this aspect, the conference has sessions dedicated to Indian compliance, technology in pharmacovigilance and other special scenarios. I am grateful to Dr Sanish Davis and Dr R K Sanghavi who readily accepted my invitations to speak at the conference on the topics I handpicked for them. Most of the other topics too have been mapped to suitable speakers who are in the process of procuring the requisite internal approvals from their respective organizations to confirm their participations. Please keep watching the conference website for updates. As you may be aware, the registrations for the conference have already started and the places are filling fast.

To register yourself for the Indian Pharmacovigilance Day 2019 conference, click on https://www.townscript.com/e/indian-pharmacovigilance-day-2019 and follow the instructions on the portal. I am happy to inform you that Life Science Academy (a business unit of Italy-based EasyB srl, represented in India by their partner agency VHEO Ventures), the organizer of the conference, has announced extension of the Early Bird Registration deadline to 30th June 2019. They have also enabled group discounts for all categories of delegates, special rates for non-industry professionals, and discounted rates for students in order to facilitate representation of all stakeholders of pharmacovigilance in India at the conference.

Before concluding, I wish to once again thank you for your goodwill for Oviya MedSafe ever since we started our journey in 2012.

Waiting to meet you through our May 2019 newsletter,

With thanks & regards,
Dr J Vijay Venkatraman
MBBS, F. Diab., MBA, FPIPA (UK)

Managing Director & CEO,
Oviya MedSafe Pvt Ltd,
Coimbatore, India
Phone: +91-422-2444442

Director,
Oviya MedSafe UK Ltd,
London, UK
Phone: +44-8452-733839

Web: www.oviyamedsafe.com
Mail: info@oviyamedsafe.com
Follow us on: Facebook,LinkedIn & Twitter

News & Events

  • 30

    Jun

    Oviya MedSafe – Proudly Representing Indian Pharmacovigilance Internationally

    Continue Reading...
  • 31

    May

    Oviya MedSafe – Balancing Subject Matter Expertise & Technology in Pharmacovigilance

    Continue Reading...
  • 30

    Apr

    Oviya MedSafe – Regulatory Pursuit Beyond Pharmacovigilance

    Continue Reading...
  • 31

    Mar

    Oviya MedSafe – Defining Dignity in Pharmacovigilance

    Continue Reading...
  • 28

    Feb

    Oviya MedSafe – Patronizing the Pharmacovigilance Pachyderm

    Continue Reading...
  • 31

    Jan

    Oviya MedSafe – Uniting Physicians for Pharmacovigilance

    Continue Reading...
  • 31

    Dec

    Oviya MedSafe – Catalyzing Pharmacovigilance Compliance

    Continue Reading...
  • 30

    Nov

    Oviya MedSafe – Epitomizing Pharmacovigilance Entrepreneurship

    Continue Reading...
  • 31

    Oct

    Oviya MedSafe – Cultivating Pharmacovigilance Standards Since 2012

    Continue Reading...
  • 30

    Sep

    Oviya MedSafe – Pioneering Peerless Partnerships with MAHs for Focused Pharmacovigilance

    Continue Reading...
View All